This renewed interest in DHODH as a target for cancer has been accompanied by the discovery of numerous inhibitors in addition to the long list of agents already described (Boukalova et al., 2020; Ladds et al., 2018; Mollick and Laín, 2020; Munier-Lehmann et al., 2013). The gene discussed is DHODH; the disease is cancer.